Journal
GENE
Volume 800, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.gene.2021.145834
Keywords
METTL3; Hepatoblastoma; Polymorphism; Susceptibility; RNA m(6)A methylation
Categories
Funding
- Natural Science Foun-dation of Guangdong Province [2019A1515010360]
- National Natural Science Foundation of China [81960294, 81560262]
- Yunnan Key Laboratory of Research on Children's Critical Diseases [202005AG070073]
- Basic Applied Study Planning Projects of Yunnan Province [2018FB130]
- Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease [2019B030301004]
Ask authors/readers for more resources
The study revealed an association between METTL3 gene polymorphisms and hepatoblastoma risk. While no significant correlation was found in single genotype analysis, individuals with 2-4 risk genotypes had an increased risk of hepatoblastoma in the combined analysis. Carriers of 2-4 risk genotypes were particularly susceptible among subjects aged under 17 months and females.
Hepatoblastoma is the most common malignant liver cancer in childhood, yet its etiology remains unclear. As an m6A methylation modifier, methyltransferase like 3 (METTL3) has an active methyltransferase domain that functionally participates in various tumor occurrence and development. However, little is known about how METTL3 polymorphisms affect the occurrence of hepatoblastoma. Here, we attempted to investigate the associations between METTL3 gene polymorphisms and hepatoblastoma risk in a seven-center case-control study. We genotyped four METTL3 polymorphisms (rs1061026 T > G, rs1061027 C > A, rs1139130 A > G, rs1263801 G > C) by TaqMan technique in 313 cases and 1446 controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the contributions of these four single nucleotide polymorphisms (SNPs) to hepatoblastoma susceptibility. In single genotype analysis, we detected no significant correlation between these four polymorphisms in METTL3 and hepatoblastoma risk. However, in the combined analysis, the presence of 2-4 risk genotypes of METTL3 was associated with an increased risk of hepatoblastoma compared with that of 0-1 risk genotypes (adjusted OR = 1.48, 95% CI = 1.03-2.12, P = 0.035). The stratified analysis further revealed that carriers of 2-4 risk genotypes are more susceptible to hepatoblastoma in the subgroups of subjects aged under 17 months (adjusted OR = 1.88, 95% CI = 1.12-3.16, P = 0.016) and females (adjusted OR = 1.79, 95% CI = 1.06-3.05, P = 0.031). Overall, our results revealed that none of these four SNPs could increase susceptibility to hepatoblastoma individually. Carriers with 2-4 risk genotypes in the combined analysis tend to increase the risk of hepatoblastoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available